Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients - 2025
Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients
Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients
Original title :
[en] P2937 Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients
Publication date :
July 2025
Event name :
ESCMID Global 2025
Event organizer :
European Society of Clinical Microbiology and Infectious Diseases